Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal
Year.
By a written consent dated as of September 20, 2022, the Board of Directors of
CURE Pharmaceutical Holding Corp. (the "Company") approved an amendment to its
certificate of incorporation to change its name to "Avenir Wellness Solutions,
Inc." (the "Amendment"). On October 14, 2022, the Company filed the Amendment
with the Secretary of State of the State of Delaware. The Company has submitted
a request to the Financial Industry Regulatory Authority, Inc. to obtain a new
trading symbol for its common stock that aligns with its new name. A new symbol
has not been issued as of the date of this Current Report on Form 8-K.
Item 7.01 Regulation FD Disclosure.
On January 17, 2023, the Company issued a press release announcing the filing of
the Amendment and the pending approval of its new trading symbol as described in
detail in Item 5.03 above. A copy of the press release is filed as Exhibit 99.1
to this Current Report on Form 8-K and is incorporated herein solely for
purposes of this Item 7.01 disclosure. Pursuant to the rules and regulations of
the Securities and Exchange Commission, the information in this Item 7.01
disclosure, including Exhibit 99.1 and information set forth therein, is deemed
to have been furnished and shall not be deemed to be "filed" under the
Securities Exchange Act of 1934, as amended.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. Description
3.1 Certificate of Amendment of Certificate of Incorporation
99.1 Press Release dated as of January 17, 2023
The cover page from this Current Report on Form 8-K, formatted in
104 Inline XBRL
2
© Edgar Online, source Glimpses